Skip to main content

Animations

MJFF Publications

1981 - 1990 of 6516 Results
Title
Year
  • Year
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD Trial
    Journal Name: Genomics, Proteomics & Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.gpb.2021.08.009
    Citation Count: 93
  • Summary Details
    OPEN
    Title: Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutants
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jbc.2022.102565
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Digitizing a Therapeutic: Development of an Augmented Reality Dual-Task Training Platform for Parkinson’s Disease
    Journal Name: Sensors
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/s22228756
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Dementia with Lewy bodies post-mortem brains reveal differentially methylated CpG sites with biomarker potential
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-022-03965-x
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Human pericytes degrade diverse α-synuclein aggregates
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0277658
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-022-01116-2
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brains
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcac274
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Parkinson's disease resting tremor severity classification using machine learning with resampling techniques
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2022.955464
    Citation Count: 9
  • Summary Details
    OPEN
    Title: A prebiotic diet modulates microglial states and motor deficits in α-synuclein overexpressing mice
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.81453
    Citation Count: 78
  • Summary Details
    OPEN
    Title: NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson’s disease using convolutional neural network
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2022.103250
    Citation Count: 19
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.